Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

quanterix corp - QTRX

QTRX

Close Chg Chg %
2.86 -0.03 -1.05%

Closed Market

2.83

-0.03 (1.05%)

Volume: 257.08K

Last Updated:

Oct 26, 2026, 4:00 PM EDT

Trade Now

Company Overview: quanterix corp - QTRX

QTRX Key Data

Open

$2.86

 Day Range

2.79 - 2.90

52 Week Range

2.15 - 8.77

 Market Cap

$134.31M

Shares Outstanding

47.29M

 Public Float

41.75M

Beta

1.01

 Rev. Per Employee

N/A

P/E Ratio

N/A

 EPS

-$2.63

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

539.07K

  

QTRX Performance

1 Week
 
 0.00%
 
1 Month
 
 -12.54%
 
3 Months
 
 -22.07%
 
1 Year
 
 -50.00%
 
5 Years
 
 -94.35%
 

QTRX Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 3
Full Ratings ➔

About quanterix corp - QTRX

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.

QTRX At a Glance

Quanterix Corp.
900 Middlesex Turnpike
Billerica, Massachusetts 01821
Phone 1-617-301-9400 Revenue 138.90M
Industry Medical Specialties Net Income -107,150,000.00
Sector Health Technology 2025 Sales Growth 1.074%
Fiscal Year-end 12 / 2026 Employees 450
View SEC Filings

QTRX Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 1.952
Price to Book Ratio 1.005
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -2.777
Enterprise Value to Sales 1.369
Total Debt to Enterprise Value 0.196

QTRX Efficiency

Revenue/Employee 308,660.00
Income Per Employee -238,111.111
Receivables Turnover 4.634
Total Asset Turnover 0.322

QTRX Liquidity

Current Ratio 2.839
Quick Ratio 2.107
Cash Ratio 1.581

QTRX Profitability

Gross Margin 46.768
Operating Margin -62.935
Pretax Margin -80.83
Net Margin -77.143
Return on Assets -24.848
Return on Equity -34.246
Return on Total Capital -32.18
Return on Invested Capital -31.162

QTRX Capital Structure

Total Debt to Total Equity 12.592
Total Debt to Total Capital 11.184
Total Debt to Total Assets 8.263
Long-Term Debt to Equity 9.915
Long-Term Debt to Total Capital 8.807
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Quanterix Corp - QTRX

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
105.52M 122.37M 137.42M 138.90M
Sales Growth
-4.55% +15.96% +12.30% +1.07%
Cost of Goods Sold (COGS) incl D&A
59.99M 51.86M 54.32M 73.94M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
7.34M 12.00M 8.36M 18.93M
Depreciation
5.54M 10.40M 6.76M 11.32M
Amortization of Intangibles
1.80M 1.60M 1.60M 7.60M
COGS Growth
+18.03% -13.56% +4.75% +36.12%
Gross Income
45.53M 70.51M 83.10M 64.96M
Gross Income Growth
-23.77% +54.88% +17.86% -21.83%
Gross Profit Margin
+43.15% +57.62% +60.47% +46.77%
2022 2023 2024 2025 5-year trend
SG&A Expense
117.89M 115.17M 135.72M 152.37M
Research & Development
25.89M 26.06M 31.08M 30.82M
Other SG&A
92.00M 89.11M 104.64M 121.55M
SGA Growth
-0.36% -2.30% +17.84% +12.27%
Other Operating Expense
- - - -
-
Unusual Expense
- 29.35M 1.33M 33.58M
EBIT after Unusual Expense
(101.70M) (45.99M) (52.62M) (121.00M)
Non Operating Income/Expense
5.07M 18.36M 14.52M 8.72M
Non-Operating Interest Income
5.13M 15.84M 14.65M 8.57M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - -
-
Interest Expense Growth
- - - -
-
Gross Interest Expense
- - - -
-
Interest Capitalized
- - - -
-
Pretax Income
(96.64M) (27.64M) (38.10M) (112.27M)
Pretax Income Growth
-67.41% +71.40% -37.86% -194.70%
Pretax Margin
-91.58% -22.58% -27.72% -80.83%
Income Tax
65.00K 719.00K 434.00K (5.12M)
Income Tax - Current - Domestic
77.00K 161.00K 37.00K 93.00K
Income Tax - Current - Foreign
368.00K 850.00K 683.00K 416.00K
Income Tax - Deferred - Domestic
- - (23.00K) (5.25M)
-
Income Tax - Deferred - Foreign
(357.00K) (292.00K) (286.00K) (381.00K)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(96.70M) (28.35M) (38.53M) (107.15M)
Minority Interest Expense
- - - -
-
Net Income
(96.70M) (28.35M) (38.53M) (107.15M)
Net Income Growth
-67.63% +70.68% -35.89% -178.09%
Net Margin Growth
-91.64% -23.17% -28.04% -77.14%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(96.70M) (28.35M) (38.53M) (107.15M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(96.70M) (28.35M) (38.53M) (107.15M)
EPS (Basic)
-2.6142 -0.7542 -1.0043 -2.513
EPS (Basic) Growth
-63.12% +71.15% -33.16% -150.22%
Basic Shares Outstanding
36.99M 37.59M 38.37M 42.64M
EPS (Diluted)
-2.6142 -0.7542 -1.0043 -2.513
EPS (Diluted) Growth
-63.12% +71.15% -33.16% -150.22%
Diluted Shares Outstanding
36.99M 37.59M 38.37M 42.64M
EBITDA
(65.02M) (32.66M) (44.26M) (68.49M)
EBITDA Growth
-22.01% +49.76% -35.51% -54.74%
EBITDA Margin
-61.61% -26.69% -32.21% -49.31%

Snapshot

Average Recommendation HOLD Average Target Price 3.167
Number of Ratings 3 Current Quarters Estimate -0.375
FY Report Date 12 / 2026 Current Year's Estimate -2.24
Last Quarter’s Earnings -0.39 Median PE on CY Estimate N/A
Year Ago Earnings -2.51 Next Fiscal Year Estimate -1.236
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 3 3 2 3
Mean Estimate -0.38 -0.43 -2.24 -1.24
High Estimates -0.33 -0.35 -2.15 -0.97
Low Estimate -0.45 -0.56 -2.33 -1.45
Coefficient of Variance -16.38 -26.38 -5.68 -19.75

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 0 0 0
OVERWEIGHT 0 0 0
HOLD 3 3 3
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Hold Hold Hold

Insider Actions for Quanterix Corp - QTRX

Date Name Shares Transaction Value
Oct 12, 2026 Michael F. Miller Chief Operating Officer 8,855 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Oct 12, 2026 Michael F. Miller Chief Operating Officer 9,689 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Oct 12, 2026 Michael F. Miller Chief Operating Officer 3,116 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Oct 12, 2026 Michael F. Miller Chief Operating Officer 30,343 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Oct 12, 2026 Michael F. Miller Chief Operating Officer 30,314 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $4.72 per share 143,082.08
Oct 12, 2026 Michael F. Miller Chief Operating Officer 30,450 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Oct 12, 2026 Michael F. Miller Chief Operating Officer 30,402 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $4.72 per share 143,497.44
Oct 12, 2026 Michael F. Miller Chief Operating Officer 30,537 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Oct 12, 2026 Michael F. Miller Chief Operating Officer 30,489 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $4.72 per share 143,908.08
Oct 12, 2026 Michael F. Miller Chief Operating Officer 30,861 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Oct 12, 2026 Michael F. Miller Chief Operating Officer 30,730 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $4.72 per share 145,045.60
Oct 12, 2026 Michael F. Miller Chief Operating Officer 31,564 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Oct 12, 2026 Michael F. Miller Chief Operating Officer 31,271 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $4.72 per share 147,599.12
Oct 12, 2026 Michael F. Miller Chief Operating Officer 922 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Oct 12, 2026 Michael F. Miller Chief Operating Officer 1,661 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Aug 17, 2026 William P. Donnelly Director 99,400 Open market or private purchase of non-derivative security Non-derivative transaction at $2.93 per share 291,242.00
Aug 17, 2026 William P. Donnelly Director 27,155 Open market or private purchase of non-derivative security Non-derivative transaction at $2.75 per share 74,676.25
Jan 16, 2026 Paul M. Meister Director 313,253 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 15, 2026 Jeffrey Thomas Elliott Director 42,792 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 7, 2026 Masoud Toloue President & CEO; Director 508,446 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $6.36 per share 3,233,716.56

Quanterix Corp in the News